X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Therapeutic Advances in Endocrinology and Metabolism

期刊標題檢索 THER ADV ENDOCR 最新評論: This journal may not be fast, but the review process feels standardize... (2023-11-09)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Therapeutic Advances in Endocrinology and Metabolism]您好,您是該頁面的第 12602 位訪客。

期刊簡介
期刊名稱Therapeutic Advances in Endocrinology and Metabolism Therapeutic Advances in Endocrinology and Metabolism
LetPub Score
6.1
50 ratings
Rate

Reputation
7.6

Influence
4.7

Speed
7.0

期刊簡稱THER ADV ENDOCRINOL
ISSN2042-0188
E-ISSN2042-0196
h-index24
CiteScore
CiteScoreSJRSNIPCiteScore Rank
7.701.3011.318
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Endocrinology, Diabetes and Metabolism
Q153 / 244

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Therapeutic Advances in Endocrinology and Metabolism delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of endocrinology and metabolism.
官方網站https://journals.sagepub.com/home/tae
在線稿件提交https://uk.sagepub.com/en-gb/asi/journal/therapeutic-advances-endocrinology-and-metabolism#submission-guidelines
開放訪問No
出版商Sage Periodicals Press
主題領域Medicine
出版國/地區United States
發行頻率
創刊年0
每年文章數37每年文章數趨勢
黃金OA百分比90.51%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ENDOCRINOLOGY & METABOLISMSCIEQ251/186
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2042-0188%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 8 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Therapeutic Advances in Endocrinology and Metabolism】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Diabetes & Metabolism JournalH-index: 36

    CiteScore: 10.40
    DIABETES-METABOLISM RESEARCH AND REVIEWSH-index: 0

    CiteScore: 17.20
    Current Osteoporosis ReportsH-index: 0

    CiteScore: 8.40
    Frontiers in EndocrinologyH-index: 51

    CiteScore: 5.70
    Endocrinology and MetabolismH-index: 0

    CiteScore: 6.60
    BMJ Open Diabetes Research & CareH-index: 0

    CiteScore: 9.30
    Metabolic Engineering CommunicationsH-index: 0

    CiteScore: 13.30
    European Thyroid JournalH-index: 0

    CiteScore: 6.70
    Journal of the Endocrine SocietyH-index: 0

    CiteScore: 5.50
    Diabetes TherapyH-index: 22

    CiteScore: 6.90
    學科內最受檢索的期刊 頁面查看次數
    Frontiers in Endocrinology177117
    Discover Oncology33033
    BMJ Open Diabetes Research & Care19354
    Diabetes & Metabolism Journal18487
    Diabetes Therapy14100
    Diabetes Therapy12732
    Archives of Endocrinology Metabolism12214
    Endocrinology and Metabolism11169
    European Thyroid Journal10636
    DIABETES-METABOLISM RESEARCH AND REVIEWS7074
  •  

    Therapeutic Advances in Endocrinology and Metabolism Therapeutic Advances in Endocrinology and Metabolism
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Therapeutic Advances in Endocrinology and Metabolism] 的評論撰寫評論
作者: 京城香萱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-09 20:19:16 評論於
This journal may not be fast, but the review process feels standardized. The reviewers' comments are detailed, with minor revisions required within a month. The submission process takes about 1.5 months for the first round of review by three reviewers, followed by a month for revisions before acceptance
(0) 讚! | 京城香萱

作者: 吐纳庚子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-06 16:15:01 評論於
This journal is not well known in the country, but it is a JCR Q2 journal. I tried to submit an article and the reviewers were easy to communicate with. The review comments were also very fair, I carefully revised according to the comments, and my article was accepted
(0) 讚! | 吐纳庚子

作者: 修然小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-02 21:04:37 評論於
A friend recommended checking out this journal, and after carefully studying it, I found it to be quite good. The impact factor is moderate and it's also easy to publish in. Seems like not many people have paid attention to it, but we've struck gold
(0) 讚! | 修然小公主

作者: 婉柔小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-09 19:06:31 評論於
So fast, how much is the layout fee for the God of the board?
(0) 讚! | 婉柔小公主

作者: Jack Stowe


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-14 16:10:07 評論於
Is this magazine only accepting review articles?
(0) 讚! | Jack Stowe

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 19:04:57 評論於
Revised, that is, modifying the response. In the submission and publication of papers to SCI journals, making appropriate modifications to the editor's letter and explaining the modified content in detail in the response letter to the editor is a step to request a reevaluation of the manuscript
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 18:38:37 評論於
Almost all free submissions that meet the academic standards for publication after review require revisions by the authors to enhance the expression and editing format before publication, such as compressing the length of the article, redesigning tables, improving the quality of illustrations, and limiting the use of irregular abbreviations. However, submissions that are returned to the authors for revisions do not mean that the article has been accepted. The final acceptance of the article depends on whether the author's modifications to the critical content and expressions of the article meet the requirements of the reviewers and editors. Typically, the materials returned to the authors for revisions include the original manuscript, reviewers' comments, and a covering letter from the editor. When authors receive the revised manuscript, they should first carefully read the modification letter and reviewers' comments. Then they should consider whether they can or are willing to accept the suggestions from the reviewers or editors and make modifications to the manuscript. The likelihood of the article being accepted can be seen from the response of the editor and reviewers to the revised manuscript. Revisions should not be rushed, and authors should carefully read and understand the reviewers' questions. Each comment from the reviewers should be answered individually (response to reviewer 1, 2, 3); specific changes made to the revised manuscript should be clearly indicated (page, lines); a letter should be sent to the editor, thanking them for their suggestions for revisions and explaining the reasons for any changes that were not made as suggested
(0) 讚! | 维尔娜菲茨杰拉德

作者: 北国博达


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 16:07:12 評論於
What does the term "courtesy return" encompass?
(0) 讚! | 北国博达

作者: 平原文波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 10:58:18 評論於
What is the process of refunds?
(0) 讚! | 平原文波

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-17 23:59:25 評論於
Has the review speed increased this year? Any other experts feeling the same?
(0) 讚! | 上清雨真

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-17 15:30:01 評論於
My supervisor said not too many people know about this journal, so the competition is relatively small. He suggested that I submit an article to give it a try
(0) 讚! | 上清雨真

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-17 14:50:07 評論於
Received the first instance reply in November, it took 42 days, I think it's acceptable
(0) 讚! | 上清雨真

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-17 12:17:58 評論於
Submitted at the end of September, received first review comments in mid-November, made minor revisions once, and returned
(0) 讚! | 上清雨真

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-17 10:38:00 評論於
Are there not many people submitting to this journal? I received the initial review reply in just 40 days and was not rejected
(0) 讚! | 上清雨真

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-17 09:03:50 評論於
The first trial takes more than 40 days, and the second trial takes one month. I wonder if we can advance the online time
(0) 讚! | 上清雨真

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-16 23:53:31 評論於
Experience sharing: I submitted a meta paper this year, and it took about 1 and a half months for the initial revision. It was not until I received the acceptance email that the entire process lasted 4 months. I am now ready to pay the fee
(0) 讚! | 上清雨真

作者: letpubyan


領域: 医学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2021-04-14 22:28:47 評論於
I originally intended to submit to that magazine, but I found out that it has already become an Open Access journal.
(0) 讚! | letpubyan

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Therapeutic Advances in Endocrinology and Metabolism] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*